Efficacy of pregabalin in neuropathic pain in paediatric oncological patients

European Journal of Paediatric Neurology

Volumn 13, Issue 4, 2009, Pages 332-336

  Vondracek, Petr ^a   Oslejskova, Hana ^a   Kepak, Tomas ^a   Mazanek, Pavel ^a   Sterba, Jaroslav ^a   Rysava, Marie ^a   Gal, Petr ^a  

^a UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Chemotherapy induced neuropathy; Neuropathic pain; Paediatric oncological patient; Pregabalin

Indexed keywords

PLATINUM DERIVATIVE; PREGABALIN; VINCA ALKALOID;

ADOLESCENT; ALLODYNIA; ARTICLE; BURNING SENSATION; CANCER PATIENT; CHILD; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DROWSINESS; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; HYPERALGESIA; MALE; NAUSEA; NEUROPATHIC PAIN; PARESTHESIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCHOOL CHILD; SOLID TUMOR; SYMPTOMATOLOGY; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; ANALGESICS; ANTINEOPLASTIC AGENTS; CHILD; FEMALE; FOLLOW-UP STUDIES; GAMMA-AMINOBUTYRIC ACID; HUMANS; MALE; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT;

EID: 67349287360     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2008.06.011     Document Type: Article

References (26)

1. Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin J Pain 16 Suppl. 3 (2000) S118-S130
2. Backonja M., and Glanzman R.L. Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials. Clin Ther 1 (2003) 81-104
3. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J Am Med Assoc 280 (1998) 1831-1836
4. Bonezzi C., and Demartini L. Treatment options in postherpetic neuralgia. Acta Neurol Scand 173 Suppl. (1999) 25-35
5. Chen S.R., Xu Z., and Pan H.L. Stereospecific effect of pregabalin on ectopic afferent discharges and neuropathic pain induced by sciatic nerve ligation in rats. Anesthesiology 95 (2001) 1473-1479
6. Diop L., Raymond F., Fargeau H., Petoux F., Chovet M., and Doherty A.M. Pregabalin (CI-1008) inhibits the trinitrobenzene sulfonic acid-induced chronic colonic allodynia in the rat. J Pharmacol Exp Ther 302 (2002) 1013-1022
7. Dooley D.J., Donovan C.M., Meder W.P., and Whetzel S.Z. Preferential action of gabapentin and pregabalin at P/Q-type voltage-sensitive calcium channels: inhibition of KC-evoked [3H]norepinephrine release from rat neocortical slices. Synapse 45 (2002) 171-190
8. Dubinsky R.M., Kabbani H., El-Chami Z., Boutwell C., and Ali H. Practice parameter: treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 63 (2004) 959-965
9. Dworkin R.H., Corbin A.E., Young Jr. J.P., Sharma U., LaMoreaux L., Bockbrader H., et al. Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60 (2003) 1274-1283
10. Eutamene H., Coelho A.M., Theodorou V., Toulouse M., Chovet M., Doherty A., et al. Antinociceptive effect of pregabalin in septic shock-induced rectal hypersensitivity in rats. J Pharmacol Exp Ther 295 (2000) 162-167
11. Field M.J., McCleary S., Hughes J., and Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 80 (1999) 391-398
12. Fink K., Dooley D.J., Meder W.P., Suman-Chauhan N., Duffy S., Clusmann H., et al. Inhibition of neuronal Ca2C influx by gabapentin and pregabalin in the human neocortex. Neuropharmacology 42 (2002) 229-236
13. Freynhagen R., Strojek K., Griesing T., Whalen E., and Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 3 (2005) 254-263
14. Friedrichsdorf S.J., and Kang T.I. The management of pain in children with life-limiting illnesses. Pediatr Clin North Am 5 (2007) 645-672
15. Golden A.S., Haut S.R., and Moshé S.L. Nonepileptic uses of antiepileptic drugs in children and adolescents. Pediatr Neurol 6 (2006) 421-432
16. Lesser H., Sharma U., LaMoreaux L., and Poole R.M. Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology 11 (2004) 2104-2110
17. Luo Z.D., Chaplan S.R., Higuera E.S., Sorkin L.S., Stauderman K.A., Williams M.E., et al. Upregulation of dorsal root ganglion a2-d calcium channel subunit and its correlation with allodynia in spinal nerve-injured rats. J Neurosci 21 (2001) 1868-1875
18. Maneuf Y.P., Hughes J., and McKnight A.T. Gabapentin inhibits the substance P facilitated KC-evoked release of [3H]glutamate from rat caudal trigeminal nucleus slices. Pain 93 (2001) 191-196
19. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
20. Rowbotham M., Harden N., Stacey B., Bernstein P., and Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. J Am Med Assoc 280 (1998) 1837-1842
21. Rowbotham M., Young J., Sharma U., and Knapp L. Pregabalin shows reduction in pain by day three of treatment: analysis of daily pain scores. J Pain 4 2 Suppl. 1 (2003) 63 [Abstract 846]
22. Ruoff G.E. Slowing the initial titration rate of tramadol improves tolerability. Pharmacotherapy 19 (1999) 88-93
23. Sabatowski R., Galvez R., Cherry D.A., Jacquot F., Vincent E., Maisonobe P., et al., the 1008-1045 Study Group. Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomized, placebo-controlled clinical trial. Pain 109 (2004) 26-35
24. Vu T.N. Current pharmacologic approaches to treating neuropathic pain. Curr Pain Headache Rep 8 (2004) 15-18
25. Wallin J., Cui J.G., Yakhnitsa V., Schechtmann G., Meyerson B.A., and Linderoth B. Gabapentin and pregabalin suppress tactile allodynia and potentiate spinal cord stimulation in a model of neuropathy. Eur J Pain 6 (2002) 261-272
26. Woolf C.J., and Mannion R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 353 (1999) 1959-1964